Bicycle Therapeutics Plc (BCYC)
4.33
-0.02
(-0.46%)
USD |
NASDAQ |
Mar 23, 14:31
Bicycle Therapeutics EPS Diluted (Quarterly) : -0.2901 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | -0.0461 |
| Autolus Therapeutics Plc | -0.2954 |
| DBV Technologies SA | -1.207 |
| Cellectis SA | -0.2621 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.12M |
| Revenue (Quarterly) | 47.89M |
| Total Expenses (Quarterly) | 68.01M |
| Enterprise Value | -307.91M |
| Gross Profit Margin (Quarterly) | 97.21% |
| Profit Margin (Quarterly) | -42.03% |
| Earnings Yield | -73.28% |
| Normalized Earnings Yield | -73.28 |